Jiangyin Concludes Golden Autumn Investment Month with 208 Projects Totaling RMB68 Billion
JIANGYIN, China, Dec. 9, 2025 /PRNewswire/ -- The 2025 Jiangyin Symposium on…
Why Transparent, Comparable, and Reliable Security Testing Matters: AV-Comparatives Highlights 2025 Enterprise EPR and EDR Results
INNSBRUCK, Austria, Dec. 9, 2025 /PRNewswire/ -- As cyberattacks continue to challenge…
Bybit CEO Ben Zhou Signals a New Era of Regulated Institutional Finance Following Full VAPO and MiCAR Approvals
DUBAI, UAE, Dec. 9, 2025 /PRNewswire/ -- At the BIG Series – Bybit…
Linglong Tire Holds 50th Anniversary Global Partners Conference, Unveiling Green-Tech Innovations and Future Strategy
YANTAI, China, Dec. 9, 2025 /PRNewswire/ -- On December 7, Linglong Tire convened…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
Manipal Hospitals Enhances Movement and Confidence Through Awareness on Movement Disorders
BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
ADFW Opens with Spotlight on Abu Dhabi’s Global Ambition and Major Humanitarian Pledge
ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Abu Dhabi Finance Week…
